Ototoxicity Enrolling by Invitation Phase 2 Trials for Ebselen (DB12610)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02819856SPI-1005 for Prevention and Treatment of Tobramycin Induced OtotoxicityTreatment